The Therapeutic Role of Nanoparticle Shape in Traumatic Brain Injury : An in vitro Comparative Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Youn, Dong Hyuk | - |
dc.contributor.author | Jung, Harry | - |
dc.contributor.author | Ngoc Minh Tran | - |
dc.contributor.author | Jeon, Jin Pyeong | - |
dc.contributor.author | Yoo, Hyojong | - |
dc.date.accessioned | 2023-02-21T05:36:47Z | - |
dc.date.available | 2023-02-21T05:36:47Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 2005-3711 | - |
dc.identifier.issn | 1598-7876 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/111490 | - |
dc.description.abstract | Objective : To perform a comparative analysis of therapeutic effects associated with two different shapes of ceria nanoparticles, ceria nanorods (Ceria NRs) and ceria nanospheres (Ceria NSs), in an in vitro model of traumatic brain injury (TBI). Methods : In vitro TBI was induced using six-well confluent plates by manually scratching with a sterile pipette tip in a 6x6-square grid. The cells were then incubated and classified into cells with scratch injury without nanoparticles and cells with scratch injury, which were treated separately with 1.16 mM of Ceria NSs and Ceria NRs. Antioxidant activities and anti-inflammatory effects were analyzed. Results : Ceria NRs and Ceria NSs significantly reduced the level of reactive oxygen species compared with the control group of SH-SY5Y cells treated with Dulbecco's phosphate-buffered saline. The mRNA expression of superoxide dismutases was also reduced in nanoparticle-treated SH-SY5Y cells, but apparently the degree of mRNA expression decrease was not dependent on the nanoparticle shape. Exposure to ceria nanoparticles also decreased the cyclooxygenase-2 expression, especially prominent in Ceria NR-treated group than that in Ceria NS-treated group. Conclusion : Ceria nanoparticles exhibit antioxidant and anti-inflammatory effects in TBI models in vitro. Ceria NRs had better antiinflammatory effect than Ceria NSs, but showed similar antioxidant activity. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한신경외과학회 | - |
dc.title | The Therapeutic Role of Nanoparticle Shape in Traumatic Brain Injury : An in vitro Comparative Study | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3340/jkns.2021.0185 | - |
dc.identifier.scopusid | 2-s2.0-85127098360 | - |
dc.identifier.wosid | 000768772600005 | - |
dc.identifier.bibliographicCitation | Journal of Korean Neurosurgical Society, v.65, no.2, pp 196 - 203 | - |
dc.citation.title | Journal of Korean Neurosurgical Society | - |
dc.citation.volume | 65 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 196 | - |
dc.citation.endPage | 203 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002815147 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | CERIA NANOPARTICLES | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordAuthor | Traumatic brain injury | - |
dc.subject.keywordAuthor | Cerium oxide | - |
dc.subject.keywordAuthor | Nanoparticles | - |
dc.identifier.url | https://jkns.or.kr/journal/view.php?doi=10.3340/jkns.2021.0185 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.